Characterization of mibefradil block of the human heart delayed rectifier hKv1.5

Journal of Pharmacology and Experimental Therapeutics

Volumn 295, Issue 2, 2000, Pages 771-778

  Perchenet, L ^a   Clement Chomienne, O ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MIBEFRADIL;

ANIMAL CELL; ARTICLE; CELL MEMBRANE DEPOLARIZATION; CELL MEMBRANE POTENTIAL; CHO CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISSOCIATION CONSTANT; DRUG MECHANISM; HEART; NONHUMAN; PATCH CLAMP; POTASSIUM CHANNEL; POTASSIUM CURRENT; PRIORITY JOURNAL; TIME; VOLTAGE CLAMP;

ANIMAL; CALCIUM CHANNEL BLOCKERS; CHO CELLS; HAMSTERS; HEART; HUMAN; ION CHANNEL GATING; KINETICS; MEMBRANE POTENTIALS; MIBEFRADIL; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; VASODILATOR AGENTS;

EID: 0033771705     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. MIRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia
2. Pharmacologic and pharmacokinetic profile of mibefradil, a T-and L-type calcium channel antagonist
3. Ion channels. A new wave for heart rhythms
4. 2+ channel blocker mibefradil on the repolarization of guinea pig, rabbit, dog, monkey and human cardiac tissue
5. Antihypertensive properties of the novel calcium antagonist mibefradil (Ro 40-5967). A new generation of calcium antagonists?
6. 2+ channel antagonist mibefradil (Ro 40-5967)
7. L- and T-type calcium currents differ in finch and rat ventricular cardiomyocytes
8. + channels
9. + channels involved in long QT syndromes, are targets for calcium channel blockers
10. Discovery and main pharmacological properties of mibefradil (Ro 40-5967), the first selective T-type calcium channel blocker
11. Electrophysiology of human cardiac cells
12. + channel current
13. + current in cultured adult human atrial myocytes
14. + channels in human T lymphocytes
15. + channels, types Kv1.1, 1.2, 1.3, 1.5 and 3.1, stably expressed in mammalian cell lines
16. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches
17. Different mechanisms of the inhibition of the transient outward current in rat ventricular myocytes
18. New developments in drug therapy of hypertension
19. + current in human ventricular myocytes
20. + currents in human fusion-competent myoblasts
21. + channel protein in explanted cardiac tissue
22. 2+ channels by Ro 40-5967
23. Mibefradil, a T-type and L-type calcium channel blocker, limits infarct size through a glibenclamide-sensitive mechanism
24. - channels in macrovascular endothelial cells
25. Dose-response characteristics of mibefradil, a novel calcium antagonist, in the treatment of essential hypertension
26. Cardiovascular profile of Ro 40-5967, a new nondihydropyridine calcium antagonist, delineated in isolated, blood-perfused dog hearts
27. Functional and biochemical characterization of the human potassium channel Kv1.5 with a transplanted carboxyl-terminal epitope in stable mammalian cell lines
28. What lessons can be learnt from withdrawal of mibefradil from the market?
29. + channel cloned from human heart
30. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel
31. Coassembly of K(V)LQT1 and mink (IsK) proteins to form cardiac I(Ks) potassium channel
32. Human vascular to cardiac tissue selectivity of L- and T-type calcium channel antagonists
33. Nonlinear pharmacokinetics of mibefradil in the dog
34. A rapidly activating and slowly inactivating potassium channel cloned from human heart. Functional analysis after stable mammalian cell culture expression
35. Time-, voltage- and state-dependent block by quinidine of a cloned human cardiac potassium channel
36. + channel cDNAs from human ventricle
37. Effects of Ro 40-5967, a new calcium antagonist and enalapril on cardiac remodeling in renal hypertensive rats
38. + current similar to Kv1.5 cloned channel currents
39. Ionic blockage of sodium channels in nerve
40. Endogenous voltage-gated potassium channels in human embryonic kidney (HEK293) cells
41. Characterization of nifedipine block of the human heart delayed rectifier, hKv1.5